deCODE chemistry & biostructures conducts integrated drug discovery and pre-clinical development services for pharmaceutical and biotechnology companies.

Our Core Competencies are

• Validated Gene-Target, Structure-Lead-IND-Clinic Paradigm
• Broad Target Experience
• Unique Business Model SLIC^TM
• "One-Stop" Integrated Drug Discovery Services including 
  • Protein Structure Determination
  • Screening and Fragments of Life^TM Lead Identification
  • Medicinal Chemistry
  • Analytical Chemistry
  • Chemical Process Development and cGMP
  • Pre-Clinical Services 

Recent News

May 29, 2009
deCODE biostructures Initiates New Collaboration with Shire Human Genetic Therapies, Inc. 

May 5, 2009
deCODE biostructures Contributes to Solutions for Swine Flu as Part of Genomics Center at SBRI 

April 16, 2009
deCODE biostructures and Mitsubishi Tanabe Pharma Corporation Initiate Fragments of Life™ Screening for Fragment Based Lead Discovery

March 16, 2009
deCODE chemistry and biostructures is Featured in the Cover Story of Chemical & Engineering News (C&E News), a Publication from the American Chemical Society

To See All News Click Here